Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

15.87 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Worldwide Upbeat ↗
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. 
Via Talk Markets
Topics Economy
News headline image
Takeda's Maribavir US Application For Post-Transplant CMV Infection Under Review ↗
The FDA has accepted for review Takeda Pharmaceutical Co Ltd's (NYSE TAK) marketing application for maribavir for cytomegalovirus (CMV) Infection. The... 
Via Benzinga
News headline image
Moderna's COVID-19 Vaccine Scores Emergency Use Nod In Japan ↗
Moderna Inc (NASDAQ: MRNA) has received emergency use approval for its mRNA COVID-19 vaccine in Japan. Takeda Pharmaceutical Co Ltd (NYSE: TAK),... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Is BioCryst a Good Stock to Buy Now? ↗
This commercial-stage drugmaker trades for less than many of its clinical-stage peers. 
Via The Motley Fool
News headline image
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Better Mood Day ↗
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion. 
Via Talk Markets
News headline image
Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first... 
Via Benzinga
News headline image
Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares ↗
Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the... 
Via Benzinga
News headline image
Takeda FY20 Profit Surges, Revenue Drops; Guides For Weak FY21 Profit ↗
Takeda Pharmaceutical Co Ltd (NYSE: TAK) reported an FY20 net profit of ¥376 billion, a 750% Y/Y increase, reflecting gains on non-core asset sales and... 
Via Benzinga
News headline image
Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ: 
Via Benzinga
News headline image
Gold Up Four Days In A Row ↗
The dollar is at a nearly 3 month low. 
Via Talk Markets
News headline image
Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com ↗
Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA... 
Via Benzinga
News headline image
Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip ↗
Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ) on Wednesday. SKLZ shares closed 9% lower... 
Via Benzinga
News headline image
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know ↗
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple... 
Via Benzinga
News headline image
Monday Markets Unhinged ↗
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan. 
Via Talk Markets
News headline image
Another Heavy News Day ↗
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week. 
Via Talk Markets
News headline image
Arrowhead's ARO-AAT Treatment Associated With Improved Fibrosis In Patients With Alpha-1 Liver Disease ↗
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has announced positive interim 48-week liver biopsy results from the Phase 2 AROAAT2002 study ... 
Via Benzinga
News headline image
Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Down Nearly 50% From All-Time Highs, Is This Pharma Giant a Good Buy? ↗
You might want to consider adding this company to your portfolio. 
Via The Motley Fool
News headline image
Friday Market Report ↗
Schlumberger Ltd of Curação today reported on its Q1 results which were good. 
Via Talk Markets
News headline image
Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions ↗
Ovid Therapeutics Inc (NASDAQ: OVID) has announced to discontinue the development of OV101 (gaboxadol), a delta (δ)-selective GABAA receptor agonist, in... 
Via Benzinga
News headline image
Electric Cancer Cure ↗
Most US stocks were down on fear of inflation and financial risks but then rose after lunch. 
Via Talk Markets
News headline image
Takeda Manufacturing Site in Belgium Pioneering Wastewater Recycling for Production
SOURCE: Takeda 
Via 3BL Media
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.